Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$2.2B |
| 2 |
Devon Energy
DVN
|
+$1.93B |
| 3 |
Seagate
STX
|
+$1.77B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$1.7B |
| 5 |
IBM
IBM
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.73B |
| 2 |
Eli Lilly
LLY
|
+$2.48B |
| 3 |
NVIDIA
NVDA
|
+$2.42B |
| 4 |
Honeywell
HON
|
+$2.41B |
| 5 |
Wells Fargo
WFC
|
+$2.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.37% |
| 2 | Healthcare | 17.54% |
| 3 | Financials | 13.55% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Broadridge
BR
$19.2B
| $1.32M | ﹤0.01% |
9,634
+242
| +3% | +$36.5K |
|
1652
Altimmune
ALT
$652M
| $1.28M | ﹤0.01% |
420,300
+172,142
| +69% | +$514K |
|
1653
Emergent Biosolutions
EBS
$291M
| $1.27M | ﹤0.01% |
151,966
+720
| +0.5% | +$6.02K |
|
|
CLYM
1654
Climb Bio
CLYM
$864M
| $1.26M | ﹤0.01% |
+96,807
| New | +$1,000K |
|
1655
Aquestive Therapeutics
AQST
$646M
| $1.25M | ﹤0.01% |
301,647
+11,587
| +4% | +$48.8K |
|
1656
InMode
INMD
$851M
| $1.25M | ﹤0.01% |
+85,751
| New | +$1.2M |
|
1657
Loews
L
$22.2B
| $1.25M | ﹤0.01% |
11,068
-890
| -7% | -$96.5K |
|
1658
Trupanion
TRUP
$1.09B
| $1.25M | ﹤0.01% |
50,487
-23,268
| -32% | -$566K |
|
1659
Beam Therapeutics
BEAM
$2.6B
| $1.25M | ﹤0.01% |
36,311
-2,513
| -6% | -$75.9K |
|
|
FDXF
1660
FedEx Freight
FDXF
$18.7B
| $1.22M | ﹤0.01% |
+8,080
| New | +$1.32M |
|
1661
lululemon athletica
LULU
$11B
| $1.2M | ﹤0.01% |
10,550
-702,756
| -99% | -$93.9M |
|
1662
Dr. Reddy's Laboratories
RDY
$9.9B
| $1.2M | ﹤0.01% |
82,711
-87,865
| -52% | -$1.19M |
|
1663
Enanta Pharmaceuticals
ENTA
$386M
| $1.19M | ﹤0.01% |
81,633
+6,673
| +9% | +$89.7K |
|
1664
Immunovant
IMVT
$8B
| $1.18M | ﹤0.01% |
30,722
+2,197
| +8% | +$66.9K |
|
1665
Evolus
EOLS
$566M
| $1.18M | ﹤0.01% |
+169,934
| New | +$1M |
|
1666
Acadia Pharmaceuticals
ACAD
$4.77B
| $1.18M | ﹤0.01% |
46,584
-3,397
| -7% | -$74.7K |
|
1667
Hormel Foods
HRL
$11.5B
| $1.18M | ﹤0.01% |
47,356
-69,147
| -59% | -$1.54M |
|
1668
IDEAYA Biosciences
IDYA
$3.7B
| $1.17M | ﹤0.01% |
31,412
-1,439
| -4% | -$44K |
|
1669
Dyne Therapeutics
DYN
$3.58B
| $1.16M | ﹤0.01% |
52,427
+3,545
| +7% | +$65.9K |
|
|
TRAX
1670
First Tracks Biotherapeutics
TRAX
$1.41B
| $1.16M | ﹤0.01% |
+57,476
| New | +$1.07M |
|
1671
Eversource Energy
ES
$26.5B
| $1.13M | ﹤0.01% |
15,621
-2,360,116
| -99% | -$163M |
|
1672
Futu Holdings
FUTU
$16.4B
| $1.13M | ﹤0.01% |
12,036
-29,952
| -71% | -$3.84M |
|
1673
Prime Medicine
PRME
$629M
| $1.12M | ﹤0.01% |
304,444
+26,324
| +9% | +$87.4K |
|
|
DRD
1674
DRDGold
DRD
$2.44B
| $1.12M | ﹤0.01% |
52,469
+30,777
| +142% | +$831K |
|
|
INIO
1675
INNIO N.V.
INIO
$15.6B
| $1.12M | ﹤0.01% |
+28,248
| New | +$1.01M |
|
Similar funds
Wellington Management Group's Q2 2026 Portfolio in Review
As of Q2 2026, Wellington Management Group held 2,097 positions worth $580B, up 8.3% from $535B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $23.6B in Q2 2026, closing 176 positions and reducing 867 holdings. Its most notable exit was Coterra Energy, an estimated $1.88B position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in Honeywell Aerospace worth $1.71B.
- Wellington Management Group's largest Q2 2026 buy was Honeywell Aerospace: 7,716,131 shares worth $1.71B.
- Wellington Management Group added most to Cardinal Health in Q2 2026, an estimated $2.2B increase.
- Wellington Management Group's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $2.73B.
- Wellington Management Group fully exited Coterra Energy in Q2 2026, selling an estimated $1.88B.
- Wellington Management Group's ten largest holdings make up 25% of its $580B portfolio in Q2 2026.
- Wellington Management Group opened 231 new positions and closed 176 in Q2 2026.
- Wellington Management Group's portfolio value rose 8.3% quarter-over-quarter to $580B.
Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.